Back to Agenda
Costing Strategies for Sustainable Drug Development
Session Chair(s)
Stella Stergiopoulos, MPH, MS
Director, Health Economic and Outcomes Research, EQRx, United States
Under Which Network Conditions Does Outsourcing to a CRO Reduce Clinical Trial Costs?
Learning Objective : Characterize critical steps in clinical study planning; Glean best budget planning and forecasting practices; Describe how to optimize partnership networks to decrease clinical trial costs and increase overall value of retaining clinical trial partners; Discuss how to apply an analytical framework for estimating sponsor outsourcing costs; Provide a directional benchmark on partner/vendor selection process costs.
Speaker(s)
Stella Stergiopoulos, MPH, MS
Director, Health Economic and Outcomes Research, EQRx, United States
Benchmarking the Clinical Budget and Outsourcing Processes
Erika Buonansegna, MSC
PhD Student, Technical University of Denmark, Denmark
Under Which Network Conditions Does Outsourcing to a CRO Reduce Clinical Trial Costs?
Kyle Given
Principal, Strategic Consulting Services, Medidata Solutions Worldwide, United States
Tracking Cost Savings During Transformational Change: A Focus on Risk-Based Monitoring
Have an account?